Cannaflos Genetics S.L.

Cannaflos Genetics SL is dedicated to contributing to the development of new cannabis cultivars registered in the EU, aiming to enhance the quality of life for patients through innovative cannabinoid-based medications. As a part of Cannaflos Group, Cannaflos Genetics brings the advantage of synergizing expertise across diverse business units to deliver holistic solutions for the ever-evolving needs of clients and the global market. Cannaflos Genetics collaborates with universities and research institutions on multiple R&D projects focused on genetic preservation, development, and breeding. With robust partnerships and our laboratory infrastructure, we are poised to elevate Cannaflos' portfolio and capabilities in custom cannabis genetics development.